[Nick Hargrave]

Positive news from Avacta this morning with the expected 2nd dose escalation news. While still not proof that the prodrug is ‘working’, it is good to see the trial continuing to move forward with good safety and tolerability

https://www.londonstockexchange.com/news-article/AVCT/second-dose-escalation-in-phase-1-trial-of-ava6000/15516302